Clausen; Jes Thorn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clausen; Jes Thorn.The latest application filed is for "antibodies against tissue factor pathway inhibitor".

Company Profile

3.13.19

Clausen; Jes Thorn - Hoeng DK
Clausen; Jes Thorn - Hong DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Against Tissue Factor Pathway Inhibitor App 20190211112 - Hilden; Ida ; et al.	2019-07-11
Targeting tissue factor to activated platelets App 20190062429 - Hilden; Ida ; et al.	2019-02-28
Targeting tissue factor to activated platelets Grant 10,106,606 - Hilden , et al. October 23, 2	2018-10-23
Antibodies Against Tissue Factor Pathway Inhibitor App 20170114147 - Hilden; Ida ; et al.	2017-04-27
Antibodies against tissue factor pathway inhibitor Grant 9,574,011 - Hilden , et al. February 21, 2	2017-02-21
Antibodies that are capable of specifically binding tissue factor pathway inhibitor Grant 9,260,518 - Hilden , et al. February 16, 2	2016-02-16
Antibodies that are capable of specifically binding tissue factor pathway inhibitor Grant 9,228,022 - Hilden , et al. January 5, 2	2016-01-05
Therapeutic factor VIII antibodies Grant 9,062,115 - Oestergaard , et al. June 23, 2	2015-06-23
Anti-Human Interleukin-20 Antibodies App 20140194599 - Pass; Jesper ; et al.	2014-07-10
Anit-Human Interleukin-20 Antibodies App 20140141001 - Pass; Jesper ; et al.	2014-05-22
Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor Grant 8,652,471 - Hilden , et al. February 18, 2	2014-02-18
Antibodies against tissue factor pathway inhibitor (TFPI) Grant 8,618,263 - Hilden , et al. December 31, 2	2013-12-31
Antibodies Against Tissue Factor Pathway Inhibitor (TFPI) App 20130344090 - Hilden; Ida ; et al.	2013-12-26
Therapeutic Factor Viii Antibodies App 20130266576 - Oestergaard; Henrik ; et al.	2013-10-10
Antibodies Against Tissue Factor Pathway Inhibitor App 20130251721 - Hilden; Ida ; et al.	2013-09-26
Antibodies Against Tissue Factor Pathway Inhibitor App 20130251722 - Hilden; Ida ; et al.	2013-09-26
Antibodies That Are Capable of Specifically Binding Tissue Factor Pathway Inhibitor App 20130253173 - Hilden; Ida ; et al.	2013-09-26
Antibodies That Are Capable of Specifically Binding Tissue Factor Pathway Inhibitor App 20130142804 - Hilden; Ida ; et al.	2013-06-06
Anti-human Interleukin-20 Antibodies App 20130039923 - Pass; Jesper ; et al.	2013-02-14
Antibodies against tissue factor pathway inhibitor Grant 8,361,469 - Hilden , et al. January 29, 2	2013-01-29
Anti-human interleukin-20 antibodies Grant 8,287,861 - Pass , et al. October 16, 2	2012-10-16
Antibodies Against Tissue Factor Pathway Inhibitor App 20110318356 - Hilden; Ida ; et al.	2011-12-29
Antibodies Against Tissue Factor Pathway Inhibitor (TFPI) App 20110268745 - Hilden; Ida ; et al.	2011-11-03
Anti-Human Interleukin-20 Antibodies App 20110091475 - Pass; Jesper ; et al.	2011-04-21
Interleukin 20 (IL-20) and its use in neovascularisation App 20060188476 - Olsen; Uffe Bang ; et al.	2006-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.